StockGuild

$OWCP Why I'm Extremely Long on This $5.00 by EOM

شراء
StockGuild تم تحديثه   
OTC:OWCP   OWC PHARMACEUTICAL RESEARCH CORP
I was in on the initial run .0030 - .10 bought and sold from .10 - $3.00 bought and sold (both times sold too early) and now .50 - $5.00 Here's why:

PROVISIONAL PATENTS TAKE ABOUT 8-12 MONTHS TO GET TURNED INTO APPROVED PATENTS.

Here's the list of $OWCP Patents:
1) patentscope.wip...h/en/detail.jsf?docId=WO20...

2) patentscope.wip...h/en/detail.jsf?docId=WO20...

3) patentscope.wip...h/en/detail.jsf?docId=WO20...

4) patentscope.wip...h/en/detail.jsf?docId=WO20...

5) patentscope.wip...h/en/detail.jsf?docId=WO20...

6) patentscope.wip...h/en/detail.jsf?docId=WO20...

7) patentscope.wip...h/en/detail.jsf?docId=WO20...

Also the Patent Document: www.docdroid.net/nVk...plication-2.pdf.html

FROM THE 8K ON APRIL 4TH: OWC Pharmaceutical Research Corp. ("OWC") is reporting the issuance on April 5, 2017 of the attached press release, announcing that as a result of the promising conclusions reported in its Form 8-K filed on March 20, 2017, the Company has received expressions of scientific and medical interest, world-wide, for its cannabinoid-based topical cream for treating psoriasis. OWCP has expanded the size and scope of its clinical studies and, as previously announced, anticipates that subject to pending regulatory approvals from applicable jurisdictions, the topical cream should be available for use by those who suffer from psoriasis in the near term.

ALSO LETS NOT FORGET 4/20

In addition we have many news outlets covering MJ which is bringing it back into the light.

CANADA LEGALIZING IT NATIONWIDE.

Too many catalysts to cover.

Once we break key resistance tomorrow we could see $2.00 by EOD
تعليق:
FDA Cannabinoid Topical Cream Study Application: clinicaltrials....how/NCT02976779?term=owc&a...

إخلاء المسؤولية

لا يُقصد بالمعلومات والمنشورات أن تكون، أو تشكل، أي نصيحة مالية أو استثمارية أو تجارية أو أنواع أخرى من النصائح أو التوصيات المقدمة أو المعتمدة من TradingView. اقرأ المزيد في شروط الاستخدام.